Fracture Liaison Service for Hip Fractures: Is It A Game Changer?

被引:1
作者
Or, Omer [1 ,2 ]
Negev, Tamar Fisher
Hadad, Vered
Shabtai, Ran
Katzir, Alona
Wei, Yotam
Liebergall, Meir
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Org, Dept Orthoped Surg, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Fac Med, IL-91120 Jerusalem, Israel
来源
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2021年 / 23卷 / 08期
关键词
biphsophonate; denusomab; teriparatide; hip fracture; osteoporosis; vitamin D; OSTEOPOROTIC FRACTURE; MORTALITY; PREVENTION; DISABILITY; WOMEN; MEN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Osteoporosis is a common medical condition in older ages. A devastating result of osteoporosis may be a hip fracture with up to 30% mortality rate in one year. The compliance rate of osteoporotic medication following a hip fracture is 20% in the western world. Objectives: To evaluate the impact of the fracture liaison service (FLS) model in the orthopedic department on patient compliance following hip fracture Methods: We performed a retrospective review of alt patients with hip fracture who were involved with FLS. We collected data regarding kidney function, calcium levels, parathyroid hormone levels, and vitamin D levels at admission. We educated the patient and family, started vitamin D and calcium supplementation and recommended osteoporotic medical treatment. We phoned the patient 6-12 weeks following the fracture to ensure treatment initiation. Results: From June 2018 to June 2019 we identified 166 patients with hip fracture who completed at least one year of follow-up. Over 75% of the patients had tow vitamin D levels and 22% had low calcium levels at admission. Nine patients (5%) died at median of 109 days. Following our intervention, 161 patients (96%) were discharged with a specific osteoporotic treatment recommendation; 121 (73%) received medication for osteoporosis on average of < 3 months after surgery. We recommended injectable medications; however, 51 (42%) were treated with oral biphsophonate. Conclusions: FLS improved the compliance rate of osteoporotic medical treatment and should be a clinical routine in every medical center.
引用
收藏
页码:490 / 493
页数:4
相关论文
共 21 条
[1]   Mortality after all major types of osteoporotic fracture in men and women: an observational study [J].
Center, JR ;
Nguyen, TV ;
Schneider, D ;
Sambrook, PN ;
Eisman, JA .
LANCET, 1999, 353 (9156) :878-882
[2]   Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention [J].
Eisman, John A. ;
Bogoch, Earl R. ;
Dell, Rick ;
Harrington, J. Timothy ;
McKinney, Ross E., Jr. ;
McLellan, Alastair ;
Mitchell, Paul J. ;
Silverman, Stuart ;
Singleton, Rick ;
Siris, Ethel .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (10) :2039-2046
[3]   Treatment of osteoporosis: Are physicians missing an opportunity? [J].
Freedman, KB ;
Kaplan, FS ;
Bilker, WB ;
Strom, BL ;
Lowe, RA .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2000, 82A (08) :1063-1070
[4]   Excess mortality attributable to hip-fracture: A relative survival analysis [J].
Frost, Steven A. ;
Nguyen, Nguyen D. ;
Center, Jacqueline R. ;
Eisman, John A. ;
Nguyen, Tuan V. .
BONE, 2013, 56 (01) :23-29
[5]   Osteoporosis in the European Union: medical management, epidemiology and economic burden [J].
Hernlund, E. ;
Svedbom, A. ;
Ivergard, M. ;
Compston, J. ;
Cooper, C. ;
Stenmark, J. ;
McCloskey, E. V. ;
Jonsson, B. ;
Kanis, J. A. .
ARCHIVES OF OSTEOPOROSIS, 2013, 8 (1-2)
[6]  
Huntjens Kirsten M B, 2014, J Bone Joint Surg Am, V96, pe29, DOI 10.2106/JBJS.L.00223
[7]   Vitamin D status and complications, readmissions, and mortality after hip fracture [J].
Ingstad, F. ;
Solberg, L. B. ;
Nordsletten, L. ;
Thorsby, P. M. ;
Hestnes, I. ;
Frihagen, F. .
OSTEOPOROSIS INTERNATIONAL, 2021, 32 (05) :873-881
[8]   An estimate of the worldwide prevalence and disability associated with osteoporotic fractures [J].
Johnell, O. ;
Kanis, J. A. .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 (12) :1726-1733
[9]   Epidemiology of osteoporosis [J].
Jordan, KM ;
Cooper, C .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2002, 16 (05) :795-806
[10]   A meta-analysis of previous fracture and subsequent fracture risk [J].
Kanis, JA ;
Johnell, O ;
De Laet, C ;
Johansson, H ;
Oden, A ;
Delmas, P ;
Eisman, J ;
Fujiwara, S ;
Garnero, P ;
Kroger, H ;
McCloskey, EV ;
Mellstrom, D ;
Melton, LJ ;
Pols, H ;
Reeve, J ;
Silman, A ;
Tenenhouse, A .
BONE, 2004, 35 (02) :375-382